Nanomedicine · 2023 · 16 citations · 43 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryCancer NanomedicineDrug EncapsulationNanomaterials For Drug DeliveryNanomedicineNanoparticle Delivery SystemsNanoparticle FormulationsAnticancer Drug LoadingCancer NanotherapyCarbodiimide-mediated CouplingDrug Delivery NanocarriersDynamic Light ScatteringNanoparticle DeliveryNanoparticle Drug TargetingTumor-targeted Drug Delivery
Aims: Panitumumab (anti-Erb)-conjugated polycaprolactone (PCL) nanoparticles loaded with bosutinib (BTNB) were used to develop a targeted drug-delivery system for colon cancer cells. Materials & methods: Using carbodiimide coupling, anti-Erb was conjugated to BTNB-loaded PCL nanoparticles. Dynamic light scattering, scanning electron microscopy, transmission electron microscopy, Fourier-transform infrared spectroscopy, differential scanning calorimetry, x-ray diffraction and thermogravimetric analysis were used to analyze nanoparticles. Results: According to in vitro studies, anti-Erb-BTNB-PCL nanoparticles inhibited HCT116 cells more than BTNB alone. Cell arrest at different phases was examined for apoptotic potential. An in vivo efficacy study showed that anti-Erb-BTNB-PCL nanoparticles could target tumors selectively. Conclusion: Anti-Erb-conjugated BTNB nanoparticles could specifically target colon cancer.
43
Brian K. Wilson, Robert K. Prud’homme · Journal of Colloid and Interface Science · 2021 · 209 citations
Natural Sciences, Materials Engineering, Materials Science +17
Bing Han, Yue Yang, Jinglin Chen et al. · International Journal of Nanomedicine · 2020 · 92 citations · Full text